Erectile Dysfunction In Young People With Type I Diabetes: Prevalence, Comorbidities And Therapeutic Response

Erectile dysfunction (ED) is a disorder defined as the consistent or recurrent inability to achieve and or maintain a penile erection sufficient for sexual satisfaction. ED occurs on average 10-15 years earlier in men with diabetes and is poorly studied in type I diabetes (DM I), being generally more severe and less responsive to therapy, namely phosphodiesterase type 5 inhibitors (PDE5I), leading to a worse quality of sexual activity in young individuals. We aim to assess the prevalence of patients with DM and their patients with glycemic control years and with the presence of other microvascular complications aged ≤60 years and also to assess rates of and predictors of response to oral treatment in ED men naïve for PDE5i.